Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.74 +0.06 (+3.57%)
As of: Oct 21, 2026 · 1:52 PM EDT

Transcode Therapeutics (RNAZ) Deferred Taxes (2026)

Updated

Analysis

Transcode Therapeutics (RNAZ) Deferred Taxes (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn -479.00 Mn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn -195.00 Mn
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn -
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn -
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -587.00 Mn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn -1.32 Bn
10 Transcode Therapeutics 1.67 Mn -40.22 Mn - 300.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300.00
Mar 31, 2026 231,309.00
API Access

Transcode Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=RNAZ&period=max&api_key=YOUR_API_KEY